Botensilimab (Fc-enhanced anti–cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti–PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas ASCO Guidelines ...
TEL AVIV - SciSparc Ltd. (NASDAQ:SPRC) announced Tuesday that its majority-owned subsidiary NeuroThera Labs Inc. (TSXV:NTLX) has been granted a patent by the Israel Patent Office for its proprietary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results